JP2003513701A - 組織工学のための生体活性を有する分解性複合材料 - Google Patents
組織工学のための生体活性を有する分解性複合材料Info
- Publication number
- JP2003513701A JP2003513701A JP2001536070A JP2001536070A JP2003513701A JP 2003513701 A JP2003513701 A JP 2003513701A JP 2001536070 A JP2001536070 A JP 2001536070A JP 2001536070 A JP2001536070 A JP 2001536070A JP 2003513701 A JP2003513701 A JP 2003513701A
- Authority
- JP
- Japan
- Prior art keywords
- composite material
- bioactive
- degradable composite
- microspheres
- material according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 72
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 34
- 239000004005 microsphere Substances 0.000 claims abstract description 75
- 238000000034 method Methods 0.000 claims abstract description 30
- 238000012377 drug delivery Methods 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 210000000988 bone and bone Anatomy 0.000 claims description 26
- 239000005313 bioactive glass Substances 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 17
- 210000001519 tissue Anatomy 0.000 claims description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 9
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000001506 calcium phosphate Substances 0.000 claims description 7
- 235000011010 calcium phosphates Nutrition 0.000 claims description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 7
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 230000010478 bone regeneration Effects 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000010899 nucleation Methods 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 5
- 229920000747 poly(lactic acid) Polymers 0.000 description 18
- 239000004626 polylactic acid Substances 0.000 description 18
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 16
- 238000007654 immersion Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 12
- 239000011575 calcium Substances 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- 239000011521 glass Substances 0.000 description 9
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 9
- 239000007943 implant Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 150000002484 inorganic compounds Chemical group 0.000 description 4
- 229910010272 inorganic material Inorganic materials 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 238000004626 scanning electron microscopy Methods 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Natural products OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 3
- 229910004298 SiO 2 Inorganic materials 0.000 description 3
- 239000003462 bioceramic Substances 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000002449 bone cell Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229920006237 degradable polymer Polymers 0.000 description 2
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- -1 silicate ions Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 101100219325 Phaseolus vulgaris BA13 gene Proteins 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 101001062854 Rattus norvegicus Fatty acid-binding protein 5 Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000004068 calcium phosphate ceramic Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000004821 effect on bone Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 238000001907 polarising light microscopy Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000007704 wet chemistry method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C4/00—Compositions for glass with special properties
- C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/32—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C12/00—Powdered glass; Bead compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Composite Materials (AREA)
- Inorganic Chemistry (AREA)
- Geochemistry & Mineralogy (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/439,183 US6328990B1 (en) | 1999-11-12 | 1999-11-12 | Bioactive, degradable composite for tissue engineering |
| US09/439,183 | 1999-11-12 | ||
| PCT/US2000/030947 WO2001034060A1 (en) | 1999-11-12 | 2000-11-10 | Bioactive, degradable composite for tissue engineering |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003513701A true JP2003513701A (ja) | 2003-04-15 |
| JP2003513701A5 JP2003513701A5 (enExample) | 2008-01-24 |
Family
ID=23743660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001536070A Pending JP2003513701A (ja) | 1999-11-12 | 2000-11-10 | 組織工学のための生体活性を有する分解性複合材料 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6328990B1 (enExample) |
| EP (1) | EP1233721B1 (enExample) |
| JP (1) | JP2003513701A (enExample) |
| AT (1) | ATE290351T1 (enExample) |
| AU (1) | AU774288B2 (enExample) |
| CA (1) | CA2391232A1 (enExample) |
| DE (1) | DE60018600T2 (enExample) |
| WO (1) | WO2001034060A1 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020155559A1 (en) * | 2001-01-17 | 2002-10-24 | Laurencin Cato T. | Biocompatible, biodegradable polymer-based, lighter than or light as water scaffolds for tissue engineering and methods for preparation and use thereof |
| AU2002258637A1 (en) | 2001-03-27 | 2002-10-08 | Board Of Regents The University Of Texas System | Biodegradable, electrically conductiong polymer for tissue engineering applications |
| CN1294885C (zh) * | 2001-06-05 | 2007-01-17 | 江苏阳生生物工程有限公司 | 人体骨组织生物工程支架制品及其制备方法和用途 |
| WO2003000156A1 (en) | 2001-06-22 | 2003-01-03 | Southern Biosystems, Inc. | Zero-order prolonged release coaxial implants |
| US20030220692A1 (en) * | 2002-02-09 | 2003-11-27 | Shapiro Irving M. | Preparations of nucleus pulposus cells and methods for their generation, identification, and use |
| AU2003304348A1 (en) * | 2002-03-15 | 2005-02-04 | The Trustees Of The University Of Pennsylvania | Fibrous composite for tissue engineering |
| AU2003251899A1 (en) * | 2002-07-10 | 2004-01-23 | University Of Florida | Sol-gel derived bioactive glass polymer composite |
| US7066962B2 (en) * | 2002-07-23 | 2006-06-27 | Porex Surgical, Inc. | Composite surgical implant made from macroporous synthetic resin and bioglass particles |
| WO2004039248A2 (en) * | 2002-10-31 | 2004-05-13 | The General Hospital Corporation | Repairing or replacing tissues or organs |
| US20060140904A1 (en) * | 2003-02-12 | 2006-06-29 | Tadeusz Wellisz | Random alkylene oxide copolymers for medical and surgical utilities |
| JP2007509716A (ja) * | 2003-10-29 | 2007-04-19 | ジェンティス インコーポレイテッド | 組織工学用の重合可能なエマルション |
| US8012210B2 (en) | 2004-01-16 | 2011-09-06 | Warsaw Orthopedic, Inc. | Implant frames for use with settable materials and related methods of use |
| EP1729675A4 (en) * | 2004-03-05 | 2011-05-18 | Univ Columbia | MULTI-PHASE BIODEGRADABLE AND EAST-INTEGRATIVE COMPOSITE SCULPTURE FOR THE BIOLOGICAL FIXATION OF SKELETAL MOLECULAR WEAVE ON BONE |
| US7189409B2 (en) * | 2004-03-09 | 2007-03-13 | Inion Ltd. | Bone grafting material, method and implant |
| JP2006101986A (ja) * | 2004-10-01 | 2006-04-20 | Olympus Corp | 球状セラミックス粒子の製造方法、細胞の播種方法および生体組織補填体の製造方法 |
| WO2006137787A1 (en) * | 2005-06-21 | 2006-12-28 | Ge Healthcare Bio-Sciences Ab | Method for cell culture |
| US20070148251A1 (en) | 2005-12-22 | 2007-06-28 | Hossainy Syed F A | Nanoparticle releasing medical devices |
| AU2007207495A1 (en) | 2006-01-19 | 2007-07-26 | Warsaw Orthopedic, Inc. | Porous osteoimplant |
| WO2007084725A2 (en) | 2006-01-19 | 2007-07-26 | Osteotech, Inc. | Injectable and moldable bone substitute materials |
| US20070249044A1 (en) * | 2006-01-30 | 2007-10-25 | University Of Illinois At Chicago | Microstructures in three dimensional gel suspensions for growth of cells |
| AU2007232187A1 (en) * | 2006-03-31 | 2007-10-11 | Csir | Bulking of soft tissue |
| US20080081362A1 (en) * | 2006-09-29 | 2008-04-03 | Daniel Keeley | Multilayered Composite for Organ Augmentation and Repair |
| US20080119927A1 (en) * | 2006-11-17 | 2008-05-22 | Medtronic Vascular, Inc. | Stent Coating Including Therapeutic Biodegradable Glass, and Method of Making |
| CN101200532B (zh) * | 2006-12-12 | 2011-04-27 | 上海杰事杰新材料股份有限公司 | 高分子量聚己内酯等可生物降解材料中空球的制备方法 |
| US8753391B2 (en) | 2007-02-12 | 2014-06-17 | The Trustees Of Columbia University In The City Of New York | Fully synthetic implantable multi-phased scaffold |
| US20100143439A1 (en) * | 2007-04-16 | 2010-06-10 | University Of Toledo | Hybrid Biomimetic Particles, Methods of Making Same and Uses Therefor |
| US20100317112A1 (en) * | 2007-04-27 | 2010-12-16 | Hyunjin Yang | Scaffolds increased specific gravity for cell culture and method for manufacturing thereof |
| WO2008142129A2 (en) * | 2007-05-22 | 2008-11-27 | Cinvention Ag | Partially degradable scaffolds for biomedical applications |
| DE102007031945A1 (de) * | 2007-07-06 | 2009-01-08 | Resoimplant Gmbh | Bioresorbierbares Implantat |
| US8227246B2 (en) | 2007-07-12 | 2012-07-24 | Discgenics | Compositions of adult disc stem cells for the treatment of degenerative disc disease |
| US8591933B2 (en) * | 2007-07-18 | 2013-11-26 | The Board Of Trustees Of The University Of Illinois | Temporal release of growth factors from 3D micro rod scaffolds for tissue regeneration |
| US9144629B2 (en) | 2010-03-03 | 2015-09-29 | Novabone Products, Llc | Ionically crosslinked materials and methods for production |
| WO2015147923A1 (en) | 2010-03-03 | 2015-10-01 | Novabone Products, Llc | Kit for delivering bone grafting materials |
| WO2011109581A1 (en) | 2010-03-03 | 2011-09-09 | Novabone Products, Llc | Devices and methods for the regeneration of bony defects |
| US10646514B2 (en) | 2013-03-14 | 2020-05-12 | Novabone Products, Llc | Processing methods of solgel-derived bioactive glass-ceramic compositions and methods of using the same |
| EP2983643A4 (en) | 2013-04-12 | 2016-12-28 | Univ Columbia | PROCESS FOR HOST CELL HOMING AND TOOTH MARK GENERATION |
| US20170342383A1 (en) | 2016-05-27 | 2017-11-30 | Corning Incorporated | Lithium disilicate glass-ceramic compositions and methods thereof |
| US10676713B2 (en) | 2016-05-27 | 2020-06-09 | Corning Incorporated | Bioactive borophosphate glasses |
| US10751367B2 (en) | 2016-05-27 | 2020-08-25 | Corning Incorporated | Bioactive glass microspheres |
| US10647962B2 (en) | 2016-05-27 | 2020-05-12 | Corning Incorporated | Bioactive aluminoborate glasses |
| KR20190073349A (ko) * | 2016-10-05 | 2019-06-26 | 본어라이브 바이오메터리얼스 오와이 | 골 이식재 |
| EP3717427A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | High liquidus viscosity bioactive glass |
| EP3717428A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | Bioactive borate glass and methods thereof |
| EP3717030A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | Bioactive glass compositions and dentin hypersensitivity remediation |
| CN111417601A (zh) | 2017-11-28 | 2020-07-14 | 康宁股份有限公司 | 化学强化的生物活性玻璃陶瓷 |
| CN108283729B (zh) * | 2018-01-31 | 2020-06-26 | 北京化工大学 | 具有可控镁离子释放行为的可注射骨修复材料及其制备方法 |
| CN109265942B (zh) * | 2018-08-16 | 2021-10-19 | 张海军 | 一种聚乳酸微球及其制备方法与应用 |
| CN109331223B (zh) * | 2018-09-25 | 2021-07-30 | 广州润虹医药科技股份有限公司 | 一种载药生物活性玻璃复合磷酸钙骨水泥及其应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997010010A1 (en) * | 1995-09-14 | 1997-03-20 | Takiron Co., Ltd. | Osteosynthetic material, composited implant material, and process for preparing the same |
| JPH1052485A (ja) * | 1996-08-12 | 1998-02-24 | Takiron Co Ltd | バイオセラミックス含有セル構造体とその製造方法 |
| WO1998046164A1 (en) * | 1997-04-11 | 1998-10-22 | Usbiomaterials Corporation | Biodegradable implant material comprising bioactive ceramic |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2651320B2 (ja) * | 1992-07-16 | 1997-09-10 | 田辺製薬株式会社 | 徐放性マイクロスフェア製剤の製造方法 |
| US5626861A (en) * | 1994-04-01 | 1997-05-06 | Massachusetts Institute Of Technology | Polymeric-hydroxyapatite bone composite |
| US6224913B1 (en) * | 1996-05-09 | 2001-05-01 | The Trustees Of The University Of Pennsylvania | Conditioning of bioactive glass surfaces in protein containing solutions |
| US5964807A (en) * | 1996-08-08 | 1999-10-12 | Trustees Of The University Of Pennsylvania | Compositions and methods for intervertebral disc reformation |
| US5972384A (en) * | 1997-10-01 | 1999-10-26 | University Of Maryland, Baltimore | Use of biologically active glass as a drug delivery system |
-
1999
- 1999-11-12 US US09/439,183 patent/US6328990B1/en not_active Expired - Lifetime
-
2000
- 2000-11-10 JP JP2001536070A patent/JP2003513701A/ja active Pending
- 2000-11-10 EP EP00991390A patent/EP1233721B1/en not_active Expired - Lifetime
- 2000-11-10 DE DE60018600T patent/DE60018600T2/de not_active Expired - Lifetime
- 2000-11-10 AU AU32623/01A patent/AU774288B2/en not_active Ceased
- 2000-11-10 CA CA002391232A patent/CA2391232A1/en not_active Abandoned
- 2000-11-10 WO PCT/US2000/030947 patent/WO2001034060A1/en not_active Ceased
- 2000-11-10 AT AT00991390T patent/ATE290351T1/de not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997010010A1 (en) * | 1995-09-14 | 1997-03-20 | Takiron Co., Ltd. | Osteosynthetic material, composited implant material, and process for preparing the same |
| JPH1052485A (ja) * | 1996-08-12 | 1998-02-24 | Takiron Co Ltd | バイオセラミックス含有セル構造体とその製造方法 |
| WO1998046164A1 (en) * | 1997-04-11 | 1998-10-22 | Usbiomaterials Corporation | Biodegradable implant material comprising bioactive ceramic |
Also Published As
| Publication number | Publication date |
|---|---|
| DE60018600T2 (de) | 2005-07-28 |
| ATE290351T1 (de) | 2005-03-15 |
| US6328990B1 (en) | 2001-12-11 |
| DE60018600D1 (de) | 2005-04-14 |
| WO2001034060A1 (en) | 2001-05-17 |
| EP1233721A1 (en) | 2002-08-28 |
| CA2391232A1 (en) | 2001-05-17 |
| AU3262301A (en) | 2001-06-06 |
| AU774288B2 (en) | 2004-06-24 |
| EP1233721B1 (en) | 2005-03-09 |
| EP1233721A4 (en) | 2003-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003513701A (ja) | 組織工学のための生体活性を有する分解性複合材料 | |
| Ducheyne et al. | Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function | |
| US8389018B2 (en) | Nano/macroporous bioactive glasses made by melt-quench methods | |
| Juhasz et al. | Bioactive ceramics: processing, structures and properties | |
| Lee et al. | Bioactivity improvement of poly (ε-caprolactone) membrane with the addition of nanofibrous bioactive glass | |
| US6867240B2 (en) | Porous composite materials | |
| US20110144765A1 (en) | Process For Producing Porous Scaffolds From Sinterable Glass | |
| JP2015502327A (ja) | リン酸カルシウム材料 | |
| El‐Ghannam et al. | Cyclosilicate nanocomposite: A novel resorbable bioactive tissue engineering scaffold for BMP and bone‐marrow cell delivery | |
| Islam et al. | Excellency of Hydroxyapatite Composite Scaffolds for Bone | |
| TR201811285T4 (tr) | Bir biyoaktif cam veya bir hibrit malzeme ile kaplanmış bir matris içeren kontrollü gözenekli bir implant. | |
| Raz et al. | Sol-gel based fabrication and properties of Mg-Zn doped bioactive glass/gelatin composite scaffold for bone tissue engineering | |
| Oudadesse et al. | Chitosan effects on glass matrices evaluated by biomaterial. MAS-NMR and biological investigations | |
| JP5578499B2 (ja) | リン酸カルシウム／生分解性ポリマーハイブリッド材料並びにその製法及びハイブリッド材料を用いたインプラント | |
| JP2005531339A (ja) | 組織工学的な整形外科用スキャッフォールド | |
| Jin et al. | Performance of evacuated calcium phosphate microcarriers loaded with mesenchymal stem cells within a rat calvarium defect | |
| Chatzistavrou et al. | Bioactive glass and glass-ceramic scaffolds for bone tissue engineering | |
| Bui et al. | Microspheres of chitosan-bioactive glass for application in orthopedic surgery. In vitro experiment | |
| CN110418771B (zh) | 凝胶浇注制备多孔玻璃和玻璃陶瓷颗粒结构 | |
| Yangin et al. | Production of strontium doped rice hull ash silica based bioactive glass–alginate composite scaffolds and in vitro simulated body fluid behaviour | |
| de Almeida Cruz et al. | Nanoceramic materials for bone regeneration: a systematic review in animal experimental studies | |
| Mutlu et al. | Bioactive Glasses/Polylactic Acid for Bone Tissue Engineering | |
| Nguyen et al. | Preparation and biomineralization of injectable hydrogel composite based chitosan-tetronic and bcp nanoparticles | |
| Su et al. | Nanoporous calcium silicate and PLGA biocomposite for bone repair | |
| KR20030006787A (ko) | 트리칼슘포스페이트를 함유한 골대체제용 키토산 비드 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071112 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071112 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071120 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110201 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110712 |